Arca
Skip to content
Tools
Tools

-olol

A beta blocker: blocks adrenaline's beta receptors, slowing the heart and lowering blood pressure.

  • Drugs ending in -olol: 37
  • Approved somewhere: 22
  • With a US drug page: 19

What it means

Stem from WHO's stem book, 2024; description by Arca
Stem
-olol
Class
Beta blockers
Sub-stems
-alol

Drugs that carry it

Approved and clinical-stage drugs in ChEMBL whose names ending in -olol or one of its sub-stems, matched by spelling; those with a US drug page link to it.
Acts on
AcebutololApprovedADRB1Beta-1 adrenergic receptor antagonist
AtenololApprovedADRB1Beta-1 adrenergic receptor antagonist
BetaxololApprovedADRB1Beta-1 adrenergic receptor antagonist
BisoprololApprovedADRB1Beta-1 adrenergic receptor antagonist
CarteololApprovedAdrenergic receptor betaAdrenergic receptor beta antagonist
EsmololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
LandiololApprovedADRB1Beta-1 adrenergic receptor antagonist
LevobunololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
MetipranololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
NadololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
NebivololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
OxprenololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
PenbutololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
PindololApprovedADRB1, ADRB2Beta-1 adrenergic receptor partial agonist
PropranololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
LevobetaxololPhase 3ADRB1Beta-1 adrenergic receptor antagonist
StanozololPhase 2ARAndrogen Receptor agonist
CeliprololApprovedADRB2, Adrenergic receptor alpha-2, ADRB1Beta-2 adrenergic receptor partial agonist
MetoprololApprovedADRB1Beta-1 adrenergic receptor antagonist
PractololApprovedADRB1Beta-1 adrenergic receptor inhibitor
TertatololApproved——
TimololApprovedADRB1, ADRB2Beta-1 adrenergic receptor antagonist
AlprenololPhase 2——
BefunololPhase 2——
BevantololPhase 2——
BopindololPhase 2——
BucindololPhase 2ADRB1, ADRB2, Adrenergic receptor alpha-1Beta-1 adrenergic receptor antagonist
BupranololPhase 2——
CloranololPhase 2——
EpanololPhase 2——
EsatenololPhase 2——
MepindololPhase 2——
TalinololPhase 2——
LabetalolApprovedAdrenergic receptorAdrenergic receptor antagonist
SotalolApprovedADRB1, KCNH2, ADRB2Beta-1 adrenergic receptor antagonist
Dilevalol—Adrenergic receptor beta, ADRB2Adrenergic receptor beta antagonist
Pronetalol—ADRB1, ADRB2Beta-1 adrenergic receptor antagonist

Stem from WHO, The use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (2024); description written by Arca. Drugs, stages, targets and mechanisms from ChEMBL (CC BY-SA 3.0). WHO

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.